FDA Authorizes Eli Lilly’s COVID-19 Antibody Therapy for Children

Contact Your Elected Officials
The Epoch Times Header

The Food and Drug Administration (FDA) on Friday expanded its emergency use authorization (EUA) of Eli Lilly and Co’s dual-antibody therapy for mild to moderate COVID-19 to all children, including newborns.

The treatment consists of bamlanivimab and etesevimab—two monoclonal antibodies that are administered by intravenous infusion. The two monoclonal antibodies are directed against the spike protein of SARS-CoV-2, to block the virus’s attachment and entry into human cells. They work by binding to different but overlapping sites on the spike protein.

The antibody treatment was first authorized for emergency use in February for people aged 12 years and older who weigh at least 88 pounds (40 kilograms), who have mild to moderate COVID-19 symptoms and are at high risk for progression to severe COVID-19, including hospitalization or death.

The FDA in September authorized use of the antibody therapy for post-exposure prevention of COVID-19 in the same population. The latest FDA authorization extends the treatment to all children, including newborns.

“Children under one year of age who are exposed to the virus that causes COVID-19 may be at particularly high risk for severe COVID-19 and this authorization addresses the medical needs of this vulnerable population,” Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

He asserted that the therapy “is not a substitute for vaccination.”

The FDA said a clinical trial including 125 children was conducted to assess the safety of the treatment, to support the authorization. Children weighing less than 88 pounds were administered doses of the monoclonal antibodies adjusted for their body weight.

“Serious adverse events including hypersensitivity, anaphylaxis, and infusion-related reactions have been observed with bamlanivimab with and without coadministration of etesevimab,” according to the FDA. “Possible side effects of bamlanivimab and etesevimab administered together include nausea, dizziness, pruritus, and rash.”

By Mimi Nguyen Ly

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

AI: A Double-Edged Sword?

AI produces innovation, revolutionizing industries from education to entertainment, yet AI tools also cause a gradual decline in human cognitive skills.

Why is the Epstein Victim List Longer than the Client List?

Bondi said her responsibility is to protect identities of underage girls sexually abused by Epstein, but a good number of victims have come forward.

Stirring the gravy

“You might be a Pennsylvanian-Italian if you claim Italian ancestry and participated in San Marziale festivities at Holy Angels Church in Kulpmont, PA.

Flood of Lies

The tragedy still unfolding after the historic Texas floods should be cause for unity, but Democrats weaponize the catastrophe for themselves.

Now Lawyers Are Looking for the Epstein List, Too!

So it turns out that when FBI Director Kash...

A Year After Trump Rally Shooting, Town Still Seeks Healing, Answers

A western PA community has rallied around the family of Corey Comperatore who was fatally shot when a gunman opened fire at a Trump rally.

5 States Discussing Plans to Build Prisons Like ‘Alligator Alcatraz’: Noem

Homeland Security Sec Kristi Noem said five Republican-led states were discussing plans to build detention sites similar to Florida’s “Alligator Alcatraz.”

Wyoming Opens Dual Mine: Coal for Power, Rare Earths for Everything Else

Brook Mine will be the first new coal mine to open in Wyoming in 50 years and first critical mineral and rare earth mine to open in the US in 70 years.

Los Angeles Mayor Signs Order Reaffirming Sanctuary City Policy, Proposes Cash Aid to Illegal Immigrants

LA Mayor Karen Bass has issued an executive directive reaffirming the city’s self-proclaimed sanctuary status in response to ongoing ICE operations.

EU Won’t Retaliate to Trump’s 30 Percent Tariff, Countermeasures on Hold Until August

EC President Ursula von der Leyen said EU will extend suspension on countermeasures to U.S. tariffs until next month while trade negotiations continue.

Trump Announces 30 Percent Tariff on EU, Mexico

President Donald Trump has announced a 30 percent tariff on imports from the European Union and Mexico, to go into effect on Aug. 1, 2025.

Tariff Windfall Drives Surprise $27 Billion US Budget Surplus in June

New data from Treasury Dept show that surging tariff revenues in June helped U.S. government post an unexpected budget surplus of $27 billion.

State Department Says Reorganization Plan to Move Ahead Quickly After Supreme Court Ruling

State Dept to reorganize plans following Supreme Court's allowing Trump admin to proceed with layoffs of fed workers and overhaul of federal agencies.
spot_img

Related Articles